Cargando…
Interdisciplinary advances reshape the delivery tools for effective NASH treatment
BACKGROUND: Nonalcoholic steatohepatitis (NASH), a severe systemic and inflammatory subtype of nonsalcoholic fatty liver disease, eventually develops into cirrhosis and hepatocellular carcinoma with few options for effective treatment. Currently potent small molecules identified in preclinical studi...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186491/ https://www.ncbi.nlm.nih.gov/pubmed/37142161 http://dx.doi.org/10.1016/j.molmet.2023.101730 |
_version_ | 1785042570132324352 |
---|---|
author | Chen, Linshan Wang, Yibing |
author_facet | Chen, Linshan Wang, Yibing |
author_sort | Chen, Linshan |
collection | PubMed |
description | BACKGROUND: Nonalcoholic steatohepatitis (NASH), a severe systemic and inflammatory subtype of nonsalcoholic fatty liver disease, eventually develops into cirrhosis and hepatocellular carcinoma with few options for effective treatment. Currently potent small molecules identified in preclinical studies are confronted with adverse effects and long-term ineffectiveness in clinical trials. Nevertheless, highly specific delivery tools designed from interdisciplinary concepts may address the significant challenges by either effectively increasing the concentrations of drugs in target cell types, or selectively manipulating the gene expression in liver to resolve NASH. SCOPE OF REVIEW: We focus on dissecting the detailed principles of the latest interdisciplinary advances and concepts that direct the design of future delivery tools to enhance the efficacy. Recent advances have indicated that cell and organelle-specific vehicles, non-coding RNA research (e.g. saRNA, hybrid miRNA) improve the specificity, while small extracellular vesicles and coacervates increase the cellular uptake of therapeutics. Moreover, strategies based on interdisciplinary advances drastically elevate drug loading capacity and delivery efficiency and ameliorate NASH and other liver diseases. MAJOR CONCLUSIONS: The latest concepts and advances in chemistry, biochemistry and machine learning technology provide the framework and strategies for the design of more effective tools to treat NASH, other pivotal liver diseases and metabolic disorders. |
format | Online Article Text |
id | pubmed-10186491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-101864912023-05-17 Interdisciplinary advances reshape the delivery tools for effective NASH treatment Chen, Linshan Wang, Yibing Mol Metab Review BACKGROUND: Nonalcoholic steatohepatitis (NASH), a severe systemic and inflammatory subtype of nonsalcoholic fatty liver disease, eventually develops into cirrhosis and hepatocellular carcinoma with few options for effective treatment. Currently potent small molecules identified in preclinical studies are confronted with adverse effects and long-term ineffectiveness in clinical trials. Nevertheless, highly specific delivery tools designed from interdisciplinary concepts may address the significant challenges by either effectively increasing the concentrations of drugs in target cell types, or selectively manipulating the gene expression in liver to resolve NASH. SCOPE OF REVIEW: We focus on dissecting the detailed principles of the latest interdisciplinary advances and concepts that direct the design of future delivery tools to enhance the efficacy. Recent advances have indicated that cell and organelle-specific vehicles, non-coding RNA research (e.g. saRNA, hybrid miRNA) improve the specificity, while small extracellular vesicles and coacervates increase the cellular uptake of therapeutics. Moreover, strategies based on interdisciplinary advances drastically elevate drug loading capacity and delivery efficiency and ameliorate NASH and other liver diseases. MAJOR CONCLUSIONS: The latest concepts and advances in chemistry, biochemistry and machine learning technology provide the framework and strategies for the design of more effective tools to treat NASH, other pivotal liver diseases and metabolic disorders. Elsevier 2023-05-02 /pmc/articles/PMC10186491/ /pubmed/37142161 http://dx.doi.org/10.1016/j.molmet.2023.101730 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Chen, Linshan Wang, Yibing Interdisciplinary advances reshape the delivery tools for effective NASH treatment |
title | Interdisciplinary advances reshape the delivery tools for effective NASH treatment |
title_full | Interdisciplinary advances reshape the delivery tools for effective NASH treatment |
title_fullStr | Interdisciplinary advances reshape the delivery tools for effective NASH treatment |
title_full_unstemmed | Interdisciplinary advances reshape the delivery tools for effective NASH treatment |
title_short | Interdisciplinary advances reshape the delivery tools for effective NASH treatment |
title_sort | interdisciplinary advances reshape the delivery tools for effective nash treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186491/ https://www.ncbi.nlm.nih.gov/pubmed/37142161 http://dx.doi.org/10.1016/j.molmet.2023.101730 |
work_keys_str_mv | AT chenlinshan interdisciplinaryadvancesreshapethedeliverytoolsforeffectivenashtreatment AT wangyibing interdisciplinaryadvancesreshapethedeliverytoolsforeffectivenashtreatment |